Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism GPR65 modulators(G protein-coupled receptor 65 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Sclerosis | Preclinical | Italy | 01 May 2026 | |
| Neoplasms | Preclinical | Italy | 01 May 2026 | |
| Neuroinflammation | Preclinical | Italy | 01 May 2026 | |
| Parkinson Disease | Preclinical | Italy | 01 May 2026 |





